|
|
|
|
|
Product Name
|
ADAMTS13 peptide (Metalloproteinase domain)
|
|
Product type
|
Proteins and Peptides
|
|
Peptide
|
This peptide was used as an immunogen for ab28274 - ADAMTS13 antibody - Metalloproteinase domain.
|
|
Specificity
|
We have a range of domain specific antibodies for this target. For a full list please see all ADAMTS13 antibodies
|
|
Tested applications
(see key)
|
ELISA, WB
|
|
Application notes
(see key)
|
Recommended dilutions ELISA: Use at an assay dependent dilution. WB: Use at an assay dependent dilution. This peptide can be used with studies using ab28274. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
|
|
Research areas
|
Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Metalloprotease >> ADAM TS Cancer >> Invasion/microenvironment >> ECM >> Extracellular matrix >> ADAM protein family Signal Transduction >> Cytoskeleton / ECM >> Extracellular Matrix >> ECM Enzymes >> ADAM Protein Family
|
|
Relevance
|
ADAMTS13, also known as von Willebrands factor cleaving protease (vWFcp), was first identified by its ability to cleave the ultra large aggregates of vWF into smaller forms in the serum. A thrombocytopenic disorder called thrombic thrombocytopenic purpura (TTR) was shown to be due to a deficiency in the cleavage of von Willebrands factor, and ADAMTS13 was identified as the enzyme responsible. ADAMTS13 cleaves the Tyr1605 to Met1606 bond in the A2 domain of vWF, a process stimulated by shear stress in the circulation and by binding to either platelet glycoprotein IBa or to heparin. The cleaved vWF leads to decreased platelet adhesion. An idiopathic form of TTR is found in patients with auto antibodies to ADAMTS13. The full length ADAMTS-1 sequence codes for a 1,427 amino acid protein, with a predicted mass of 153.6 kDa, but glycosylation and the abundance of cysteine residues gives ADAMTS-13 an apparent molecular weight of about 190 kDa on reduced SDS PAGE gels. The variants reported include 1,371, 1,340 and 344 amino acids, with predicted mass of 130.3, 144.5 and 36.7 kDa respectively. Many bands of varying sizes can be seen on Western blots, between 110-190 kDa, perhaps indicating differentially processed ADAMTS-13.
|
|
|
|
|
Purity
|
>95% by SDS-PAGE
|
|
Storage buffer
|
Preservative: None Constituents: 0.001% Tween 20, 30mM HEPES, 2mM EDTA, 150mM Sodium chloride, pH 6.75
|
|
Form
|
Liquid
|
|
Concentration
|
1.000 mg/ml
|
|
Storage instructions
|
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
|
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this ADAMTS13 peptide (Metalloproteinase domain) is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
| |
|
Search PubMed (MEDLINE) for references to ADAMTS13
|
| |
ADAMTS13 peptide (Metalloproteinase domain) - more information
|
Customer reviews (feedback) regarding ADAMTS13 peptide (Metalloproteinase domain) |
Customer FAQs regarding ADAMTS13 peptide (Metalloproteinase domain) |
Protocols for ADAMTS13 peptide (Metalloproteinase domain) |
Price and availability of products related to ADAMTS13 peptide (Metalloproteinase domain) |
| |
ADAMTS13 peptide (Metalloproteinase domain) - related products:
|
|
|
| |
ADAMTS13 peptide (Metalloproteinase domain) - other tools:
|
Contact Abcam with a Technical Enquiry about ADAMTS13 peptide (Metalloproteinase domain) |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"